Kohei Hasegawa1, Rachel W Linnemann2, Jonathan M Mansbach3, Nadim J Ajami4, Janice A Espinola5, Joseph F Petrosino4, Pedro A Piedra6, Michelle D Stevenson7, Ashley F Sullivan5, Amy D Thompson8, Carlos A Camargo5. 1. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; khasegawa1@partners.org. 2. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia; 3. Department of Medicine, Boston Children's Hospital, Boston, Massachusetts; 4. Alkek Center for Metagenomics and Microbiome Research and. 5. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; 6. Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, Texas; 7. Kosair Children's Hospital, Louisville, Kentucky; and. 8. Alfred I. duPont Hospital for Children, Wilmington, Delaware.
Abstract
BACKGROUND: Little is known about the association of gut microbiota, a potentially modifiable factor, with bronchiolitis in infants. We aimed to determine the association of fecal microbiota with bronchiolitis in infants. METHODS: We conducted a case-control study. As a part of multicenter prospective study, we collected stool samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 115 age-matched healthy controls. By applying 16S rRNA gene sequencing and an unbiased clustering approach to these 155 fecal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. RESULTS: Overall, the median age was 3 months, 55% were male, and 54% were non-Hispanic white. Unbiased clustering of fecal microbiota identified 4 distinct profiles: Escherichia-dominant profile (30%), Bifidobacterium-dominant profile (21%), Enterobacter/Veillonella-dominant profile (22%), and Bacteroides-dominant profile (28%). The proportion of bronchiolitis was lowest in infants with the Enterobacter/Veillonella-dominant profile (15%) and highest in the Bacteroides-dominant profile (44%), corresponding to an odds ratio of 4.59 (95% confidence interval, 1.58-15.5; P = .008). In the multivariable model, the significant association between the Bacteroides-dominant profile and a greater likelihood of bronchiolitis persisted (odds ratio for comparison with the Enterobacter/Veillonella-dominant profile, 4.24; 95% confidence interval, 1.56-12.0; P = .005). In contrast, the likelihood of bronchiolitis in infants with the Escherichia-dominant or Bifidobacterium-dominant profile was not significantly different compared with those with the Enterobacter/Veillonella-dominant profile. CONCLUSIONS: In this case-control study, we identified 4 distinct fecal microbiota profiles in infants. The Bacteroides-dominant profile was associated with a higher likelihood of bronchiolitis.
BACKGROUND: Little is known about the association of gut microbiota, a potentially modifiable factor, with bronchiolitis in infants. We aimed to determine the association of fecal microbiota with bronchiolitis in infants. METHODS: We conducted a case-control study. As a part of multicenter prospective study, we collected stool samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 115 age-matched healthy controls. By applying 16S rRNA gene sequencing and an unbiased clustering approach to these 155 fecal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. RESULTS: Overall, the median age was 3 months, 55% were male, and 54% were non-Hispanic white. Unbiased clustering of fecal microbiota identified 4 distinct profiles: Escherichia-dominant profile (30%), Bifidobacterium-dominant profile (21%), Enterobacter/Veillonella-dominant profile (22%), and Bacteroides-dominant profile (28%). The proportion of bronchiolitis was lowest in infants with the Enterobacter/Veillonella-dominant profile (15%) and highest in the Bacteroides-dominant profile (44%), corresponding to an odds ratio of 4.59 (95% confidence interval, 1.58-15.5; P = .008). In the multivariable model, the significant association between the Bacteroides-dominant profile and a greater likelihood of bronchiolitis persisted (odds ratio for comparison with the Enterobacter/Veillonella-dominant profile, 4.24; 95% confidence interval, 1.56-12.0; P = .005). In contrast, the likelihood of bronchiolitis in infants with the Escherichia-dominant or Bifidobacterium-dominant profile was not significantly different compared with those with the Enterobacter/Veillonella-dominant profile. CONCLUSIONS: In this case-control study, we identified 4 distinct fecal microbiota profiles in infants. The Bacteroides-dominant profile was associated with a higher likelihood of bronchiolitis.
Authors: Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Grace M Lee; Joshua A Salomon; Jennifer F Friedman; Patricia L Hibberd; Dennis Ross-Degnan; Eva Zasloff; Sitso Bediako; Donald A Goldmann Journal: Pediatrics Date: 2005-04 Impact factor: 7.124
Authors: Jonathan M Mansbach; Kohei Hasegawa; David M Henke; Nadim J Ajami; Joseph F Petrosino; Chad A Shaw; Pedro A Piedra; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: J Allergy Clin Immunol Date: 2016-04-06 Impact factor: 10.793
Authors: Shu Mei Teo; Danny Mok; Kym Pham; Merci Kusel; Michael Serralha; Niamh Troy; Barbara J Holt; Belinda J Hales; Michael L Walker; Elysia Hollams; Yury A Bochkov; Kristine Grindle; Sebastian L Johnston; James E Gern; Peter D Sly; Patrick G Holt; Kathryn E Holt; Michael Inouye Journal: Cell Host Microbe Date: 2015-04-09 Impact factor: 21.023
Authors: Christopher J Stewart; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Zhaozhong Zhu; Liming Liang; Carlos A Camargo; Kohei Hasegawa Journal: J Infect Dis Date: 2019-05-24 Impact factor: 5.226
Authors: Kohei Hasegawa; Rachel W Linnemann; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; Lauren G Fiechtner; Joseph F Petrosino; Carlos A Camargo Journal: Pediatr Int Date: 2016-12-22 Impact factor: 1.524
Authors: Kohei Hasegawa; Rachel W Linnemann; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; Joseph F Petrosino; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Amy D Thompson; Carlos A Camargo Journal: Pediatr Infect Dis J Date: 2017-11 Impact factor: 2.129
Authors: David X Zheng; Elie J Mitri; Vebhav Garg; Cassandra C Crifase; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: Acad Pediatr Date: 2019-06-26 Impact factor: 3.107
Authors: Jonathan M Mansbach; Ying Shelly Qi; Janice A Espinola; Kohei Hasegawa; Henry T Puls; Ashley F Sullivan; Carlos A Camargo Journal: J Pediatr Date: 2021-09-29 Impact factor: 4.406
Authors: Hebah A Al Khatib; Shilu Mathew; Maria K Smatti; Nahla O Eltai; Sameer A Pathan; Asmaa A Al Thani; Peter V Coyle; Muna A Al Maslamani; Hadi M Yassine Journal: Pathogens Date: 2021-06-17